News | September 17, 2025
Lilly to build $5 billion manufacturing facility in Virginia
This marks the first of four new U.S. manufacturing sites that Lilly plans to announce this year
This marks the first of four new U.S. manufacturing sites that Lilly plans to announce this year
Encouraging early detection and breaking the silence around men’s health
IND application for EB-003 expected in early 2026
Dr. Brown brings extensive international experience in oncology and radiopharmaceutical development,
EU approval makes Novo Nordisk’s oral semaglutide the first and only oral GLP-1 RA to reduce cardiovascular death, heart attack and stroke
A new medical-grade Amodel PPA delivers high heat resistance, electrically insulative properties, and biocompatibility for advanced single-use medical instruments and assemblies
Raludotatug deruxtecan is a specifically engineered, potential first-in-class CDH6-directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo
Drug Hunter is already relied upon by researchers at more than 200 leading organizations, including Eli Lilly, Biogen, Merck KGaA, Isomorphic Labs, Deerfield Management
We are taking Ayurveda to the world as a sustainable healthcare solution: Union Minister Prataprao Jadhav
The discussions are expected to pave the way for the creation of a consolidated national knowledge-sharing platform on IT-enabled Ayush services,
Subscribe To Our Newsletter & Stay Updated
